Llwytho...
Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke
Most of the contraindications to the administration of intravenous (IV) recombinant tissue plasminogen activator (rtPA) originated as exclusion criteria in major stroke trials. These were derived from expert consensus for the National Institute of Neurological Disorders and Stroke (NINDS) trial. Des...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Neurohospitalist |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SAGE Publications
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530420/ https://ncbi.nlm.nih.gov/pubmed/26288669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1941874415578532 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|